Сайтотек

Quick links

Choose a section

Quick links to important sections

Advertisements

Сайтотек

Advertisements
Advertisements
Advertisements

Overview of Сайтотек

Property Description
Active ingredient Misoprostol
Form Oral tablet
Pharmacological class Prostaglandin Analog
General purpose Gastrointestinal cytoprotection
Origin Synthetic PGE1 analog

Сайтотек is a recognized prescription-only medicine whose single active component is Misoprostol, consistently presented in the form of an oral tablet. This compound is classified pharmacologically as a Prostaglandin E1 Analog, placing it within the broader category of gastrointestinal agents. This pharmacological identity confirms the drug chemically mimics the structure and function of natural protective substances in the body.

Misoprostol is a synthetic analog of the body's natural prostaglandin E1 (PGE1). This synthetic modification is essential for rendering the substance stable for oral administration and capable of delivering a sustained therapeutic effect, a feature that distinguishes it from the naturally occurring compound. Its recognized importance for fundamental public health needs is well-established.

The primary general benefit of this medicine is to offer robust and clinically recognized gastrointestinal cytoprotection for the lining of the stomach and duodenum. Misoprostol achieves this by replacing the action of protective prostaglandins that may be deficient. This function involves reinforcing the physical barrier of the stomach mucosa and simultaneously acting to reduce the secretion of damaging gastric acid, actively defending the digestive lining against chronic irritation.

Regulatory References

  1. Misoprostol on WHO Model List of Essential Medicines
Advertisements

What side effects are possible with Сайтотек?

Possible Side Effects and Safety Information

The safety profile of Сайтотек (misoprostol) is characterized by a specific set of adverse reactions, particularly concerning the reproductive system, and common gastrointestinal effects.

Critical Safety Restrictions (Boxed Warning)

The most significant safety information is the Boxed Warning regarding use in pregnant women. Administration during pregnancy can cause abortion, premature birth, and birth defects (teratogenicity). It is contraindicated for its approved indication (prevention of NSAID-induced ulcers) in women who are pregnant, or in women of childbearing potential unless they require therapy and can comply with strict contraceptive measures and regular pregnancy testing. There is a serious risk of uterine rupture, particularly when used during pregnancy to induce labor or abortion, especially in women with a history of C-section or other uterine surgery.

Common Adverse Reactions

The most frequently reported side effects are dose-related and affect the gastrointestinal system:

  • Very Common: Diarrhea, Abdominal pain.
  • Common: Nausea, Vomiting, Constipation, Flatulence, Dyspepsia.

Diarrhea and abdominal pain typically occur early in the course of therapy and are often transient, but rare instances of profound diarrhea leading to severe dehydration have been reported.

Serious and Less Common Adverse Reactions

Beyond the reproductive risks, other reported serious or less common adverse reactions include anaphylactic reaction, severe menorrhagia (heavy menstrual bleeding), and dizziness or headache.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documentation defines the overdose profile of Misoprostol based on specific documented clinical manifestations and mandated emergency actions. The toxic dose in humans is not definitively established in prescribing information, but the focus is on the symptoms of excessive systemic exposure.

Overdose Entity Official Regulatory Statement
Documented Manifestations Sedation, tremor, and convulsions (seizures), along with dyspnea (difficulty breathing), fever, palpitations, hypotension (low blood pressure), and bradycardia (slow heart rate) [1, 2].
Severe Outcomes May include marked hypotension and, in relevant cases, serious uterotonic effects such as uterine rupture [3].
Population-Specific Note Patients with impaired kidney function may have slower clearance, potentially increasing the risk of adverse effects from excessive exposure [1].

Regulators explicitly require immediate medical attention for a suspected overdose. Emergency services (e.g., 911) must be contacted if the person has collapsed, experienced a seizure, has severe trouble breathing, or cannot be awakened [4]. Official management is restricted to symptomatic and supportive therapy, as no specific antidote is known [2, 5]. Supportive measures may include the use of activated charcoal to reduce further absorption [5]. Dialysis is generally considered inappropriate for drug removal [1].

Advertisements

Therapeutic Uses of Сайтотек

What Misoprostol Treats: Main Uses and Benefits

Misoprostol, a synthetic prostaglandin E1 analog, is commonly used for its supportive role in the digestive system and its relevance to uterine function. Its use is considered relevant for easing the symptoms related to inflammatory or irritative states in the stomach. Specifically, it may assist with managing symptoms related to inflammatory or irritative states in patients who take nonsteroidal anti-inflammatory drugs (NSAIDs). The support generally assists with easing the overall symptom load linked to organ-specific functional stress.

Misoprostol is also applied across therapeutic domains where additional symptomatic support is needed in obstetrical and gynecological settings. It is often applied across conditions presenting with acute episodes where short-term symptomatic assistance is needed. It is commonly used to help with recurrent or episodic manifestations related to miscarriage, may assist with medical termination of pregnancy, and is applied in addressing symptoms related to heightened physiological activity during labor, such as for cervical ripening. The assistance may help patients cope more steadily with symptom fluctuations and supports patients during difficult episodes.

“This assistance may help maintain a sense of stability when symptoms are more noticeable.”

Quick Fact: Relevant for Easing Symptoms related to Inflammatory or Irritative States

Regulatory References

  1. NIH MedlinePlus overview of Misoprostol
Advertisements

Eligibility and Restrictions for Use

The official regulatory profile for Misoprostol (Сайтотек) defines eligibility through explicit population constraints and absolute prohibitions. The medicine is absolutely contraindicated in pregnant women when used for its approved gastrointestinal indication, due to its established abortifacient and teratogenic risks. Any patient with a confirmed hypersensitivity to Misoprostol or any other prostaglandin is also categorically prohibited from use.

To manage the severe risk of fetal exposure, regulatory agencies mandate strict requirements for all women of childbearing potential; these individuals must have a negative pregnancy test shortly before starting therapy and must be capable of using effective contraceptive measures continuously during the course of treatment.

Regarding age groups, the safety and effectiveness have not been established in children and adolescents under 18 years, and consequently, use is not recommended in the pediatric population. For older adults, the usual dosage is generally permitted, though caution is advised. Organ function is also addressed: while no routine adjustment is typically required for hepatic impairment, caution is necessary for patients with impaired renal function, where a dose reduction may be warranted if the standard dose is not tolerated, based strictly on official labeling.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for misoprostol details interactions primarily related to pharmacodynamic effects and altered systemic exposure.


Drug and Substance Interaction Patterns

Co-administration with magnesium-containing antacids results in a pharmacokinetic interaction that reduces the maximum plasma concentration ( C max) and total systemic exposure ( AUC) of misoprostol acid. Taking the drug with food similarly diminishes the C max of misoprostol acid.

A pharmacodynamic interaction exists with other potent uterotonic agents, such as oxytocin or carboprost. Regulatory documents state that combining misoprostol with these substances may lead to additive or synergistic uterotonic activity.

Specific pharmacokinetic studies documented no effect on the drug levels of ibuprofen, diclofenac, antipyrine, propranolol, or diazepam when co-administered.

Population-Dependent Exposure Alterations

Systemic exposure is officially noted to be increased in specific populations. Patients with renal impairment show approximately a doubling of the half-life, C max, and AUC of misoprostol acid. An increased AUC is also documented in subjects over 64 years of age.


Interaction-Related Restrictions

Misoprostol is formally restricted for use in pregnancy for the reduction of NSAID-induced ulcers due to its inherent uterotonic activity.

Advertisements

Mechanism of Action

Prostaglandin Receptor Agonism

The primary mechanism involves agonist action on E Prostanoid ( EP) receptors, particularly EP3 and EP2 subtypes, mimicking the effects of natural prostaglandins. This initiates intracellular signaling cascades, such as the inhibition of cAMP and the release of intracellular Ca^2+, which dictates all subsequent physiological outcomes.

Dual Modulation of Gastric Function

Сайтотек modulates the gastric system by binding to EP3 receptors on parietal cells, which ultimately decreases stomach acid secretion while simultaneously enhancing mucosal blood flow and the production of protective bicarbonate and mucus. This combined action contributes to the regulation of the gastric mucosal barrier integrity and contributes to the modulation of gastric pH and protective factor levels.

Inducing Uterine Contraction

The drug targets EP2 and EP3 receptors on myometrial smooth muscle cells, leading to a rise in intracellular Ca^2+ that activates the contraction machinery. This powerful signaling cascade results in increased force and frequency of uterine contractions (uterotonic effect) and promotes the necessary softening and thinning of the cervix. These core physiological changes, the increased force and frequency of uterine contraction, are direct results of the drug's effect on the smooth muscle system.

Advertisements

Dosage and Administration Information

The administration of misoprostol (Сайтотек) is governed by specific instructions detailing its oral use, dosage, and timing. The medicine is primarily supplied as tablets in official strengths of 100 micrograms (mcg) and 200 mcg for oral administration, which is the required route for the gastroprotection indication.

For standard use in adults, the standard regimen involves taking 200 mcg four times daily (QID). A lower dose of 100 mcg four times daily may be used if the standard 200 mcg dose is not well-tolerated by the patient. Proper use requires specific contextual intake conditions: the oral tablet must be consistently taken with food to minimize potential gastrointestinal effects associated with administration.

Official guidance specifies the precise timing of administration for the QID schedule, requiring the last dose of the day to be taken at bedtime. The duration of use is also regulated, requiring the administration to continue for the entire duration that the patient is taking the co-administered nonsteroidal anti-inflammatory drug (NSAID).

Dose modification rules for specific populations are defined in the label. For older adults or patients with renal impairment, the medicine may be started at the lower 100 mcg dose four times daily to improve tolerability. If a dose is missed, the general procedure is to take the dose as soon as remembered, unless it is almost time for the next scheduled dose, at which point the missed dose is skipped.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research on Gastrointestinal Protection

Misoprostol, a synthetic prostaglandin E1 analog, is primarily studied for its ability to help protect the gastrointestinal (GI) lining. Research confirms its efficacy in reducing the risk of NSAID-induced gastric ulcers in high-risk patients, such as the elderly or those with a history of ulcers. Randomized, placebo-controlled trials have demonstrated that co-therapy with misoprostol reduces the occurrence of serious upper GI complications (like perforation, obstruction, or bleeding) in patients taking nonsteroidal anti-inflammatory drugs (NSAIDs) for chronic conditions.

Uterine and Obstetrical Research

Studies have extensively investigated misoprostol's uterotonic properties—its ability to stimulate uterine contractions and cause cervical softening. Clinical research, including systematic reviews and meta-analyses, supports its use in regimens for medication abortion and for cervical ripening and labor induction. Research has evaluated various administration routes (oral, vaginal, sublingual, buccal) and dosing schedules to optimize outcomes in obstetrical settings. The combined regimen with mifepristone is frequently studied, though misoprostol-only protocols are also a subject of ongoing clinical trials for effectiveness and safety, particularly in first-trimester termination.

Safety Profile Findings

Clinical data consistently notes that common side effects are dose-related, primarily diarrhea and abdominal cramping. Due to its uterine effects, misoprostol is contraindicated for GI protection in pregnant individuals, as studies have shown it can lead to serious adverse fetal and maternal events.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Сайтотек (FAQ)


Q: Is Сайтотек considered a long-term medication?

According to official instructions, the drug is intended to be taken for the entire duration that a patient is simultaneously taking the co-administered nonsteroidal anti-inflammatory drug (NSAID) therapy. The duration of use is therefore tied directly to the period of NSAID therapy.

Q: Can I drive or operate machinery while taking Сайтотек?

Regulatory safety data lists potential side effects that affect the central nervous system, such as dizziness and headache. Regulatory documents contain a warning that patients experiencing these effects should be aware of these potential risks when operating machinery or driving.

Q: What research is currently being done on Сайтотек?

The medicine is the subject of ongoing clinical trials registered with government authorities. Studies continue to evaluate effectiveness and safety, particularly in obstetrical settings, as part of continued research into the drug's approved and investigated uses.

Q: How long after starting Сайтотек might I notice a change?

Studies reviewed by regulatory bodies indicate that the effect of the medicine on reducing gastric acid secretion is described as apparent within 30 minutes after taking the oral dose. This onset refers to the drug's activity on the stomach lining.

Q: Does taking Сайтотек affect lab test results?

Regulatory information does not typically document that the use of this medicine interferes with the results of standard laboratory tests (such as blood work or urinalysis).

Q: Does Сайтотек cause weight change?

Adverse reaction data indicates that weight changes have been reported as a side effect. However, according to the available clinical data summaries, the frequency of this effect is currently classified as incidence not known.

Q: Will alcohol affect how Сайтотек works?

Official regulatory information notes that alcohol consumption may increase the risk of developing a stomach ulcer. This may counteract the goal of the medicine, which is to help protect the stomach lining.

Q: How quickly does Сайтотек leave the body after the last dose?

Official regulatory data on the medicine's absorption indicates that the active form has a terminal half-life of 20 to 40 minutes following oral administration. A half-life is the time it takes for the concentration of the medicine in the body to be reduced by half. The majority of the substance is then excreted in the urine.

Q: Does Сайтотек have any known interactions with herbal supplements?

Regulatory prescribing information advises patients to inform their prescribing doctor about any supplements, herbs, or vitamins they are taking, due to the possibility of certain interactions.

Q: Is the medication known to interact with birth control pills?

The regulatory label specifies that effective contraception must be used by women of child-bearing potential due to the drug’s significant risks in pregnancy. However, the label does not typically list a specific interaction that would reduce the effectiveness of common hormonal birth control pills themselves.

Q: Is there a specific patient information leaflet (PIL) for Сайтотек?

Yes, official governmental instructions confirm that the medicine is to be dispensed with an official Patient Information Leaflet (PIL). This practice helps ensure patients receive the necessary written safety and usage guidance.

Advertisements

How should Сайтотек be stored and disposed of?

How to Store and Dispose of Сайтотек (Misoprostol)

Official regulatory information requires specific storage and disposal practices to maintain product stability and ensure public safety.

Storage Requirements

Storage Parameter Official Requirement
Temperature Store at or below 25 C (or 30 C, depending on the product license). Do not store above the stated maximum limit.
Moisture Protection Keep in the original blister packaging at all times. This is essential to protect the tablets from moisture, which can cause degradation.
Child Safety Store the medication out of the reach of children.

Disposal Instructions

Unused, leftover, or expired tablets should not be disposed of in household trash or flushed down the toilet. Follow official governmental guidance by returning the product to a drug take-back program or a designated pharmaceutical collection site. This procedure prevents environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Сайтотек found in:

A-Z Index: